Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guanglin Xu

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Immunopharmacology|December 5, 2025
DXFD-1 alleviates DSS-induced ulcerative colitis by targeting NF-κB and Nrf2 signalingSai Li, Xinyu Fu, Cheng Cheng, et al.
Vascular and Endovascular Surgery|May 19, 2012
Effect of heparin-derived oligosaccharide on vascular smooth muscle cell proliferationLi Li, Wei Li, Zhong Ren, et al.
European Journal of Pharmacology|November 5, 2018
Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growthLin Wang, Jing Wang, Yuanyuan Cao, et al.
Biomedical Chromatography : BMC|January 8, 2025
Pharmacokinetics Integrated With Network Pharmacology to Investigate the Potential Mechanism of Lu-Jiao Fang Inhibited Endothelial-to-Mesenchymal Transition in Pressure Overload-Induced Cardiac FibrosisXiaoli Shi, Jingya Ma, Wei Liu, et al.
Chembiochem : a European Journal of Chemical Biology|June 16, 2026
Harnessing the Versatility of SAM-Dependent Enzymes: From Mechanism to ApplicationYaming Zhao, Shuaiqi Meng, Mengyi Chen, et al.
Plos One|November 28, 2017
Robust iterative closest point algorithm based on global reference point for rotation invariant registrationShaoyi Du, Yiting Xu, Teng Wan, et al.
Basic & Clinical Pharmacology & Toxicology|December 30, 2022
Bortezomib inhibits hepatocellular carcinoma via the Hippo-Yes-associated protein signalling pathwayYu Liao, Kejun Hu, Wangwang Liu, et al.
International Immunopharmacology|September 19, 2023
EuHD1 protects against inflammatory injury driven by NLRP3 inflammasomeHuanhuan Qiu, Wei Wang, Kejun Hu, et al.
Oncotarget|July 21, 2016
YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acidGuanglin Xu, Jing Wang, Fangfang Wu, et al.
Neoplasia (New York, N.Y.)|March 6, 2018
COX-2 Forms Regulatory Loop with YAP to Promote Proliferation and Tumorigenesis of Hepatocellular Carcinoma CellsGuanglin Xu, Ying Wang, Weijie Li, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Immunopharmacology|December 5, 2025
DXFD-1 alleviates DSS-induced ulcerative colitis by targeting NF-κB and Nrf2 signalingSai Li, Xinyu Fu, Cheng Cheng, et al.
Vascular and Endovascular Surgery|May 19, 2012
Effect of heparin-derived oligosaccharide on vascular smooth muscle cell proliferationLi Li, Wei Li, Zhong Ren, et al.
European Journal of Pharmacology|November 5, 2018
Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growthLin Wang, Jing Wang, Yuanyuan Cao, et al.
Biomedical Chromatography : BMC|January 8, 2025
Pharmacokinetics Integrated With Network Pharmacology to Investigate the Potential Mechanism of Lu-Jiao Fang Inhibited Endothelial-to-Mesenchymal Transition in Pressure Overload-Induced Cardiac FibrosisXiaoli Shi, Jingya Ma, Wei Liu, et al.
Chembiochem : a European Journal of Chemical Biology|June 16, 2026
Harnessing the Versatility of SAM-Dependent Enzymes: From Mechanism to ApplicationYaming Zhao, Shuaiqi Meng, Mengyi Chen, et al.
Plos One|November 28, 2017
Robust iterative closest point algorithm based on global reference point for rotation invariant registrationShaoyi Du, Yiting Xu, Teng Wan, et al.
Basic & Clinical Pharmacology & Toxicology|December 30, 2022
Bortezomib inhibits hepatocellular carcinoma via the Hippo-Yes-associated protein signalling pathwayYu Liao, Kejun Hu, Wangwang Liu, et al.
International Immunopharmacology|September 19, 2023
EuHD1 protects against inflammatory injury driven by NLRP3 inflammasomeHuanhuan Qiu, Wei Wang, Kejun Hu, et al.
Oncotarget|July 21, 2016
YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acidGuanglin Xu, Jing Wang, Fangfang Wu, et al.
Neoplasia (New York, N.Y.)|March 6, 2018
COX-2 Forms Regulatory Loop with YAP to Promote Proliferation and Tumorigenesis of Hepatocellular Carcinoma CellsGuanglin Xu, Ying Wang, Weijie Li, et al.
Pageof 4